Modivcare INC

Market Movers (8-K)

See all →
NASDAQ
ModivCare Inc. successfully completed its financial restructuring, reducing funded debt by over 85% and securing $100 million in new capital, transitioning to private ownership.
Worse than expected
Capital raise
NASDAQ
ModivCare Inc. announced the immediate resignation of director David Mounts Gonzales, effective November 9, 2025, as its stock transitions to the OTC Expert Market.
Worse than expected
NASDAQ
Modivcare Inc. received a Nasdaq delisting notice and will have its common stock suspended following its voluntary Chapter 11 bankruptcy filing and delinquency in its quarterly report.
Delay expected
Worse than expected
Capital raise
NASDAQ
Modivcare Inc. has initiated voluntary Chapter 11 proceedings to implement a comprehensive financial restructuring, aiming to reduce its funded debt by approximately $1.1 billion and transition ownership to new investors.
Worse than expected
Capital raise
NASDAQ
ModivCare Inc. announced it has regained full compliance with Nasdaq's market value of publicly held shares requirement, ensuring its continued listing on The Nasdaq Global Select Market.
Better than expected
NASDAQ
ModivCare Inc. announced that all proposed measures, including the election of seven directors and the approval of executive compensation, passed at its 2025 annual meeting of stockholders.

Quarterly Earnings (10-Q)

See all →
NASDAQ
ModivCare Inc. reports significant losses and details its ongoing Chapter 11 bankruptcy proceedings, which will eliminate existing common stock value.
Worse than expected
Delay expected
Capital raise
NASDAQ
ModivCare Inc. has filed for Chapter 11 bankruptcy reorganization and been delisted from Nasdaq, with its common stock now trading on the OTC Expert Market.
Capital raise
Worse than expected
NASDAQ
ModivCare Inc. reports a net loss for Q1 2025 and expresses substantial doubt about its ability to continue as a going concern due to financial challenges and debt obligations.
Worse than expected
Capital raise
NASDAQ
ModivCare's Q3 2024 results reveal a net loss and concerns about meeting debt covenants, raising substantial doubt about the company's ability to continue as a going concern.
Worse than expected
Capital raise
NASDAQ
ModivCare's Q2 2024 results show consistent revenue year-over-year but a significant net loss due to a goodwill impairment charge.
Worse than expected
NASDAQ
ModivCare's first quarter 2024 results show a revenue increase but also a larger net loss compared to the same period last year.
Worse than expected
Capital raise

Annual Reports (10-K)

NASDAQ
ModivCare Inc.'s 10-K filing reveals a year of financial challenges, including net losses, strategic shifts, and ongoing efforts to address liquidity concerns.
Delay expected
Capital raise
Worse than expected
NASDAQ
ModivCare Inc.'s 10-K filing details its capital stock, anti-takeover provisions, and corporate governance structure, alongside financial data and risk factors.
Worse than expected

Insider Trading (Form 4)

See all →
NASDAQ
ModivCare's Executive VP of Personal Care Services, Chelsey Berstler, disposed of 807 shares of common stock to cover tax withholding obligations related to a restricted stock unit award.
NASDAQ
AI Catalyst Fund, LP has significantly increased its holdings in ModivCare Inc through a series of open market purchases of common stock.
NASDAQ
Coliseum Capital Management, along with related entities and individuals, has significantly increased its holdings in ModivCare Inc. through a series of open market purchases.
Better than expected
NASDAQ
Q Global Capital Management, a significant shareholder of ModivCare Inc, has sold a substantial number of shares in a series of transactions between January 10th and January 13th, 2025.
Worse than expected
NASDAQ
Director David A. Coulter acquired 1,953 shares of ModivCare Inc. common stock on December 31, 2024, as part of the company's non-employee director compensation program.
NASDAQ
Q Global Capital Management, along with related entities, has increased its holdings in ModivCare Inc. through a series of open market purchases.

Proxy Statements (Def-14A)

See all →
NASDAQ
ModivCare Inc. has filed its definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
ModivCare Inc. has released its proxy statement outlining proposals for the 2025 Annual Meeting of Stockholders, including the election of directors, executive compensation, and ratification of the independent auditor.
Worse than expected
NASDAQ
ModivCare Inc. has adjourned its Special Meeting of Stockholders to March 13, 2025, to ensure the release of its fourth quarter and full year 2024 financial results beforehand.
Delay expected
NASDAQ
ModivCare Inc. has announced the adjournment of its special meeting of stockholders to March 13, 2025, to allow for the release of its fourth quarter and full year 2024 financial results beforehand.
Delay expected
NASDAQ
ModivCare is holding a special stockholder meeting to approve a transaction involving the issuance of $30 million in new second lien notes and the exchange of $20.165 million of existing senior notes for new second lien notes with Coliseum Capital.
Capital raise
NASDAQ
ModivCare obtains $105 million in incremental financing, appoints a Chief Transformation Officer, and initiates a strategic review of assets to bolster its financial position and future growth.
Worse than expected
Capital raise

Schedule 13D - Activist Investments

See all →
NASDAQ
ModivCare Inc. has initiated Chapter 11 bankruptcy proceedings with a prearranged plan, which Coliseum Capital Management and its affiliates have joined as consenting creditors.
Worse than expected
Capital raise
NASDAQ
AI Catalyst Fund's David Mounts Gonzales has resigned from ModivCare Inc.'s Board of Directors, with the fund intending to continue engagement on the company's Chapter 11 restructuring.
Worse than expected
NASDAQ
AI Catalyst Fund's David Mounts Gonzales, a significant shareholder, has been appointed to the Board of Directors of ModivCare Inc., effective March 7, 2025.
NASDAQ
The AI Catalyst Fund, LP has increased its beneficial ownership in ModivCare Inc. to 14.9% through recent open market purchases totaling 420,000 shares.
NASDAQ
The AI Catalyst Fund, LP and its affiliates have increased their beneficial ownership in ModivCare Inc. to 12% of outstanding common stock, acquiring an additional 312,500 shares.
NASDAQ
The AI Catalyst Fund, LP and its affiliates have disclosed a 9.8% beneficial ownership stake in ModivCare Inc., signaling intent to engage with management and the Board to enhance shareholder value.
Capital raise

Schedule 13G - Passive Investments

NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.2% of ModivCare Inc.'s common stock.
NASDAQ
Q Global Capital Management, L.P. and its affiliated entities have filed an amended Schedule 13G, disclosing a complete divestment of their beneficial ownership in ModivCare Inc.
Worse than expected
NASDAQ
Silvercrest Asset Management Group LLC, Silvercrest L.P., and Silvercrest Asset Management Group Inc. have jointly reported a passive beneficial ownership of 0.2% in ModivCare Inc.'s common stock as of December 31, 2024.
NASDAQ
HG Vora Capital Management, LLC and its principal, Parag Vora, have filed an amended Schedule 13G, reporting zero beneficial ownership of ModivCare Inc.'s common stock.
Worse than expected
NASDAQ
Q Global Capital Management, L.P. and its affiliated entities have reported a passive beneficial ownership of 8.55% in ModivCare Inc.'s common stock.